The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / August / Can Portal Hypertension Testing Go Non-invasive
Clinical care Microscopy and imaging Technology and innovation

Can Portal Hypertension Testing Go Non-invasive?

Combining routine laboratory findings with elastography and imaging may improve diagnostic triage

08/21/2026 News 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Topic Commentary

Share

4 Topic Commentaries

Can Portal Hypertension Testing Go Non-invasive?

Can Portal Hypertension Testing Go Non-invasive?

  • Richard L. Ehman
    Richard L. Ehman, MD

    Radiology; Magnetic Resonance Elastography

    •

    Mayo Clinic

    MR elastography is a technique for imaging the mechanical properties of tissue.

    Source
  • Bo Zhu
    Bo Zhu, PhD

    Biomedical Imaging; MRI Methods

    •

    MGH/HST Martinos Center for Biomedical Imaging, Harvard Medical School

    We combined two imaging techniques that measure different biophysical properties of liver fibrosis—tissue stiffness and collagen content—to stage the severity of fibrotic progression.

    Source
  • Olaya Brewer Gutierrez
    Olaya Brewer Gutierrez, MBBS

    Gastroenterology; Endoscopic Ultrasound

    •

    Johns Hopkins Medicine

    When liver doctors need to know whether a patient is at risk for cirrhosis or cancer, we can now use EUS to see for ourselves.

    Source
  • William Palmer
    William Palmer, MD

    Gastroenterology; Hepatology; Noninvasive Liver Staging

    •

    Mayo Clinic

    We also have the most advanced imaging tests that in many cases eliminate the need for an invasive liver biopsy to diagnose the stage of the disease.

    Source

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Intense Intestines
Microscopy and imaging
Intense Intestines

January 19, 2024

1 min read

Some powerful fluorescent microscopy in this Image of the Month…

Context Matters in Cancer Biology
Microscopy and imaging
Context Matters in Cancer Biology

December 27, 2021

1 min read

Akoya is leading the way with spatial phenotypic signatures – a novel class of biomarkers for predicting response to immunotherapy

When Pathology Goes 3D
Microscopy and imaging
When Pathology Goes 3D

February 2, 2022

1 min read

Stratifying cancers with non-destructive 3D pathology

Sacrificing Safety for Speed?
Microscopy and imaging
Sacrificing Safety for Speed?

February 4, 2022

3 min read

Wide adaptation of antigen testing could increase the risk of exposure to infectious SARS-CoV-2 samples

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.